067630 — HLB Life Science Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩485bn
- KR₩632bn
- KR₩46bn
Annual cashflow statement for HLB Life Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -49,292 | -54,360 | -5,913 | 6,207 | -99,944 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 31,288 | 33,396 | -16,684 | -30,348 | 78,929 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1,509 | -13,900 | 5,126 | -13,747 | -7,133 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -14,084 | -29,744 | -10,016 | -32,005 | -22,933 |
| Capital Expenditures | -2,610 | -11,654 | -21,522 | -27,466 | -25,942 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 11,432 | -60,990 | 12,639 | -10,315 | -8,691 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 8,822 | -72,643 | -8,883 | -37,781 | -34,633 |
| Financing Cash Flow Items | -128 | 800 | — | 55 | 7,029 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -641 | 102,096 | 4,786 | 105,744 | 18,259 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5,903 | -275 | -14,210 | 35,956 | -39,434 |